Literature DB >> 22054301

Kinetic and mechanistic insight into the thermodynamic degradation of saxagliptin.

G Scott Jones1, Scott A Savage, Sabrina Ivy, Patrick L Benitez, Antonio Ramirez.   

Abstract

The dipeptidyl peptidase-IV inhibitor saxagliptin (Onglyza) can undergo a thermodynamically favored cyclization to form the corresponding cyclic amidine. The kinetics and mechanism of this conversion were examined to develop a commercial synthesis that afforded saxagliptin with only trace levels of this key byproduct. Important findings of this work are the identification of a profound solvent effect and the determination of an autocatalytic pathway. Both of these phenomena result from transition structures involving proton transfer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22054301     DOI: 10.1021/jo202052a

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  4 in total

1.  Unstabilized azomethine ylides for the stereoselective synthesis of substituted piperidines, tropanes, and azabicyclo[3.1.0] systems.

Authors:  Michael A Ischay; Michael K Takase; Robert G Bergman; Jonathan A Ellman
Journal:  J Am Chem Soc       Date:  2013-02-11       Impact factor: 15.419

2.  A facile synthesis of cysteine-based diketopiperazine from thiol-protected precursor.

Authors:  Di Zhang; Wayne Wang
Journal:  R Soc Open Sci       Date:  2018-06-20       Impact factor: 2.963

3.  Understanding and Kinetic Modeling of Complex Degradation Pathways in the Solid Dosage Form: The Case of Saxagliptin.

Authors:  Blaž Robnik; Blaž Likozar; Baifan Wang; Tijana Stanić Ljubin; Zdenko Časar
Journal:  Pharmaceutics       Date:  2019-09-02       Impact factor: 6.321

4.  Oxidative cyanation of N-aryltetrahydroisoquinoline induced by visible light for the synthesis of α-aminonitrile using potassium thiocyanate as a "CN" agent.

Authors:  Bing Yi; Ning Yan; Niannian Yi; Yanjun Xie; Xiaoyong Wen; Chak-Tong Au; Donghui Lan
Journal:  RSC Adv       Date:  2019-09-19       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.